Horse Melanoma in Grey Horses and Welfare Management

Grey horses face a near-universal risk of melanoma development, with over 80% affected by age 15, creating lifelong welfare management challenges that affect comfort, performance, and quality of life.

Key Facts

Approximately 80% of grey horses develop melanoma by age 15
Grey coat color results from progressive depigmentation linked to melanocyte dysregulation
Perianal and perineal locations are most common, causing pain during defecation
Tail base, salivary glands, and parotid glands are frequently affected
Melanomas in horses are often slow-growing but can become locally invasive or metastasize
Cimetidine has shown limited efficacy in slowing progression
Surgical excision, immunotherapy, and chemotherapy are treatment options for accessible tumors

Welfare Considerations

The welfare burden of equine melanoma is chronic and progressive. Perianal tumors cause pain during normal defecation and can interfere with reproduction. Large neck and parotid tumors may affect swallowing. Horses may mask discomfort until lesions are advanced. Regular veterinary monitoring, early intervention for growing or obstructive tumors, and pain management are essential to maintaining quality of life for affected grey horses.

What You Can Do

Schedule regular veterinary examinations for melanoma monitoring in grey horses
Document tumor sizes with photographs to track growth rates
Learn signs of perianal discomfort including tail rubbing, reluctance to defecate, and posture changes
Discuss emerging immunotherapy options with an equine oncologist
Support equine oncology research through veterinary school foundations